New Opioid Plan Increases Penalties for Sacklers
MedTruth Editors · March 15, 2022
A deal has been reached between the Sackler Family and the nine remaining states in the nationwide opioid settlement.
Legal DevelopmentsMedTruth Editors · March 15, 2022
A deal has been reached between the Sackler Family and the nine remaining states in the nationwide opioid settlement.
Legal DevelopmentsMedTruth Editors · August 22, 2023
The Office of the U.S. Trustee issued a formal complaint about the settlement, arguing that the deal protects the Sackler Family.
Laws + CongressMedTruth Editors · August 10, 2023
The DOJ is taking the case to the Supreme Court in an effort to prevent a bankruptcy plan that would shield the Sackler family from opioid lawsuits.
Legal DevelopmentsMedTruth Editors · March 15, 2022
A deal has been reached between the Sackler Family and the nine remaining states in the nationwide opioid settlement.
Legal DevelopmentsMedTruth Editors · August 22, 2023
The Office of the U.S. Trustee issued a formal complaint about the settlement, arguing that the deal protects the Sackler Family.
Laws + CongressMedTruth Editors · August 10, 2023
The DOJ is taking the case to the Supreme Court in an effort to prevent a bankruptcy plan that would shield the Sackler family from opioid lawsuits.
Legal DevelopmentsMedTruth Editors · January 12, 2022
Judge McMahon rejected the bankruptcy settlement plan that would have resolved thousands of opioid epidemic lawsuits against Purdue Pharma.
Legal DevelopmentsMedTruth Editors · December 16, 2021
A group of U.S. states is urging a federal judge to reject a settlement that may benefit Oxycontin maker Purdue Pharma.
Legal DevelopmentsMedTruth Editors · September 17, 2021
With the approval, the Sacklers will pay $4.5 billion from the family’s personal fortune over nine years and will relinquish control of the company to a government-run entity.
Legal DevelopmentsMedTruth Editors · August 22, 2023
The Office of the U.S. Trustee issued a formal complaint about the settlement, arguing that the deal protects the Sackler Family.
Laws + CongressMedTruth Editors · August 10, 2023
The DOJ is taking the case to the Supreme Court in an effort to prevent a bankruptcy plan that would shield the Sackler family from opioid lawsuits.
Legal DevelopmentsMedTruth Editors · March 15, 2022
A deal has been reached between the Sackler Family and the nine remaining states in the nationwide opioid settlement.
Legal DevelopmentsMedTruth Editors · January 12, 2022
Judge McMahon rejected the bankruptcy settlement plan that would have resolved thousands of opioid epidemic lawsuits against Purdue Pharma.
Legal DevelopmentsMedTruth Editors · December 16, 2021
A group of U.S. states is urging a federal judge to reject a settlement that may benefit Oxycontin maker Purdue Pharma.
Legal DevelopmentsMedTruth Editors · September 17, 2021
With the approval, the Sacklers will pay $4.5 billion from the family’s personal fortune over nine years and will relinquish control of the company to a government-run entity.
Legal DevelopmentsMedTruth Editors · August 25, 2021
Under the proposed bankruptcy plan, Purdue Pharma would be reorganized into a new entity.
Legal DevelopmentsMedTruth Editors · July 12, 2021
Fifteen states have chosen to accept Purdue Pharmaceutical's $4.5 billion opioid settlement offer.
NewsCarah Wertheimer · November 25, 2019
While the U.S. observes urgent calls for bans on vaping products, the Sackler family catapults the opioid crisis abroad, with their affiliate company Mundipharma promoting OxyContin in China. Additionally, last week brought about several foodborne illness outbreaks, new findings on the rising prevalence of anal cancer, and a promising HIV vaccine discovery.
NewsJames Parker · October 21, 2019
Last week in medical brought about delay in an opioid trial against Purdue Pharmaceuticals and the Sackler family while the two determine how much of the settlement the Sacklers should pay. Meanwhile, actions were made against BIA-ALCL in Australia and Ireland, where warnings were sent to the public. Ireland's mesh-injured population is denied financial compensation for their harm.
NewsJames Parker · September 16, 2019
In this week's MT Weekly, Purdue Pharma and the Sacklers negotiated settlements, while pharmaceutical manufacturer Mallinckrodt agreed to a $30 million settlement. Trials on talc and Roundup brought stalemates. Still, global HIV efforts and criticisms of JUUL e-cigarettes bring hope for public health.
Health FeaturesS. Nicole Lane · May 23, 2019
The Sackler family has profited for years from their personal connections to Purdue Pharma amid the opioid crisis. Now, esteemed museums like the Met, Tate Modern, and the Guggenheim decline the Sackler Family Donations following public backlash.
Legal DevelopmentsJanuary 12, 2022
December 16, 2021
September 17, 2021
August 25, 2021
July 12, 2021
November 25, 2019
October 21, 2019
May 23, 2019